We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 1,261 results
  1. Maffucci syndrome complicated by giant chondrosarcoma in the left ankle with an IDH1 R132C mutation: a case report

    Background

    Maffucci syndrome (MS) is a rare, nonhereditary congenital mesodermal dysplasia characterized by multiple enchondromas and hemangiomas,...

    Haiyan Lv, Hantao Jiang, ... Rangteng Zhu in World Journal of Surgical Oncology
    Article Open access 29 June 2022
  2. Novel biomarkers and age-related metabolite correlations in plasma and dried blood spots from patients with succinic semialdehyde dehydrogenase deficiency

    Background

    Previous work has identified age-related negative correlations for γ-hydroxybutyric acid (GHB) and γ-aminobutyric acid (GABA) in plasma of...

    Trevor Kirby, Dana C. Walters, ... K. Michael Gibson in Orphanet Journal of Rare Diseases
    Article Open access 23 September 2020
  3. MTHFD2 in healthy and cancer cells: Canonical and non-canonical functions

    Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) is a mitochondrial enzyme of the folate-mediated one-carbon metabolism pathway. MTHFD2 has become...

    Natalia Pardo-Lorente, Sara Sdelci in npj Metabolic Health and Disease
    Article Open access 15 March 2024
  4. Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genes

    Oncogenic metabolic reprogramming impacts the abundance of key metabolites that regulate signaling and epigenetics. Metabolic vulnerability in the...

    Rhuthuparna Malayil, Yogita Chhichholiya, ... Anjana Munshi in Medical Oncology
    Article 11 May 2023
  5. Increased antioxidant response in medium-chain acyl-CoA dehydrogenase deficiency: does lipoic acid have a protective role?

    Background

    Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency (MCADD) is the most frequent fatty acid oxidation (FAO) defect in humans....

    Zahra Nochi, Rune Isak Dupont Birkler, ... Rikke Katrine Jentoft Olsen in Pediatric Research
    Article 11 February 2020
  6. The functional roles of TCA cycle metabolites in cancer

    The tricarboxylic acid cycle (TCA cycle) has been known for decades as a hub for generating cellular energy and precursors for biosynthetic pathways....

    Joseph Eniafe, Shuai Jiang in Oncogene
    Article 16 April 2021
  7. Ivosidenib: A Review in Advanced Cholangiocarcinoma

    Ivosidenib (Tibsovo ® ), a first-in-class, oral small molecule, potent and selective inhibitor of mutant isocitrate dehydrogenase 1 (mIDH1), is...

    James E. Frampton in Targeted Oncology
    Article 19 October 2023
  8. L-2hydroxyglutaric acid rewires amino acid metabolism in colorectal cancer via the mTOR-ATF4 axis

    Oncometabolites, such as D/L-2-hydroxyglutarate (2HG), have directly been implicated in carcinogenesis; however, the underlying molecular mechanisms...

    Sho Tabata, Yasushi Kojima, ... Tomoyoshi Soga in Oncogene
    Article Open access 06 March 2023
  9. Liver metabolomics reveals potential mechanism of Jieduan-Niwan formula against acute-on-chronic liver failure (ACLF) by improving mitochondrial damage and TCA cycle

    Background

    Acute-on-chronic liver failure (ACLF) is a refractory disease with high mortality, which is characterized by a pathophysiological process...

    Jiajun Liang, **aoyi Wei, ... Qiuyun Zhang in Chinese Medicine
    Article Open access 30 November 2023
  10. Redox homeostasis dysregulation in noise-induced hearing loss: oxidative stress and antioxidant treatment

    Noise exposure is an important cause of acquired hearing loss. Studies have found that noise exposure causes dysregulated redox homeostasis in...

    Yuhang Zhou, Chaoyou Fang, ... Danyang Zhou in Journal of Otolaryngology - Head & Neck Surgery
    Article Open access 11 December 2023
  11. Associations of liver function with plasma biomarkers for Alzheimer’s Disease

    Background

    Blood-based biomarkers for Alzheimer’s disease (AD) are promising to be used in clinical settings. The liver is an important degradation...

    Bin Zhang, Cheng Zhang, ... Dantao Peng in Neurological Sciences
    Article 04 January 2024
  12. Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges

    Cardiac metabolism is vital for heart function. Given that cardiac contraction requires a continuous supply of ATP in large quantities, the role of...

    Julia Ritterhoff, Rong Tian in Nature Reviews Cardiology
    Article 26 May 2023
  13. Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective

    Biliary tract cancers (BTCs) are a heterogeneous group of tumors that are rare in Western countries and have a poor prognosis. Three subgroups are...

    Cindy Neuzillet, Pascal Artru, ... David Malka in Targeted Oncology
    Article Open access 01 January 2023
  14. Oncometabolites in cancer: from cancer cells to the tumor microenvironment

    Oncometabolites refer to pro-oncogenic metabolites that are aberrantly accumulated due to distorted metabolic pathways in cancer cells, and play a...

    Luoyi Chen, Min Huang in Holistic Integrative Oncology
    Article Open access 11 June 2024
  15. Exploring the potential of asparagine restriction in solid cancer treatment: recent discoveries, therapeutic implications, and challenges

    Asparagine is a non-essential amino acid crucial for protein biosynthesis and function, and therefore cell maintenance and growth. Furthermore, this...

    Marina Gabriel Fontes, Carolina Silva, ... Gisele Monteiro in Medical Oncology
    Article 15 June 2024
  16. Genomic medicine advances for brain tumors

    Cancer genome profiling has revealed important genetic alterations that serve as prognostic indicators and guides for treatment decisions, enabling...

    Shinichiro Koizumi, Tomoya Oishi, ... Kazuhiko Kurozumi in International Journal of Clinical Oncology
    Article 10 May 2024
  17. Isocitrate dehydrogenase 1 mutation enhances 24(S)-hydroxycholesterol production and alters cholesterol homeostasis in glioma

    Isocitrate dehydrogenase (IDH) mutation is the most important initiating event in gliomagenesis, and the increasing evidence shows that IDH mutation...

    Risheng Yang, Yuanlin Zhao, ... **g Ye in Oncogene
    Article 27 August 2020
  18. D-mannose alleviates intervertebral disc degeneration through glutamine metabolism

    Background

    Intervertebral disc degeneration (IVDD) is a multifaceted condition characterized by heterogeneity, wherein the balance between catabolism...

    Zheng-Lin Dong, **n Jiao, ... Hai-Rong Tao in Military Medical Research
    Article Open access 06 May 2024
  19. Unveiling the metabolic landscape of pulmonary hypertension: insights from metabolomics

    Pulmonary hypertension (PH) is regarded as cardiovascular disease with an extremely poor prognosis, primarily due to irreversible vascular...

    Huixue Ba, Yingfan Guo, ... **aohui Li in Respiratory Research
    Article Open access 28 May 2024
  20. The role of TET2 in solid tumors and its therapeutic potential: a comprehensive review

    Indeed, tumors are a significant health concern worldwide, and understanding the underlying mechanisms of tumor development is crucial for effective...

    Wenxin Da, Ziyu Song, ... Jie Ma in Clinical and Translational Oncology
    Article 10 April 2024
Did you find what you were looking for? Share feedback.